Risk factor
Good trading liquidity
Profitability factor
Strong margins and returns
About
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of STVN is 27 and suggests 77% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell